Epidemiology and prevention of stroke: a worldwide perspective

References

• Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol.6(2), 182–187 (2007).
   PubMed Web of Science ®Google Scholar
• WHO. The Global Burden of Disease: 2004 Update. WHO, Geneva, Switzerland (2008).
   Google Scholar
• O’Donnell MJ, Xavier D, Liu L et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case–control study. Lancet376(9735), 112–123 (2010).
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Bushnell CD, Adams RJ et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke42(2), 517–584 (2011).
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ338, b1665 (2009).
   PubMed Web of Science ®Google Scholar
• Sharma M, Hakim AM. The management of hypertension for primary stroke prevention: a proposed approach. Int. J. Stroke6(2), 144–149 (2011).
   PubMedGoogle Scholar
• Arguedas JA. Blood pressure targets: are clinical guidelines wrong? Curr. Opin. Cardiol.25(4), 350–354 (2010).
   PubMedGoogle Scholar
• Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database Syst. Rev.3, CD004349 (2009).
   Google Scholar
• Cushman WC, Evans GW, Byington RP et al. Effects of intensive blood-pressure control in Type 2 diabetes mellitus. N. Engl. J. Med.362(17), 1575–1585 (2010).
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with Type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation123(24), 2799–2810 (2011).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Diener HC, Yusuf S et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA306(19), 2137–2144 (2011).
   PubMed Web of Science ®Google Scholar
• Cooper-DeHoff RM, Gong Y, Handberg EM et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA304(1), 61–68 (2010).
   PubMed Web of Science ®Google Scholar
• Mancia G, Schumacher H, Redon J et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation124(16), 1727–1736 (2011).
   PubMed Web of Science ®Google Scholar
• Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA305(9), 913–922 (2011).
   PubMed Web of Science ®Google Scholar
• Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J. Hypertens.28(7), 1366–1372 (2010).
   PubMed Web of Science ®Google Scholar
• Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J. Am. Coll. Cardiol.54(20), 1827–1834 (2009).
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events. Am. J. Cardiol.106(6), 825–829 (2010).
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Sarwar N, Perry P et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA302(18), 1993–2000 (2009).
   PubMed Web of Science ®Google Scholar
• Canoui-Poitrine F, Luc G, Bard JM et al. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc. Dis.30(3), 252–259 (2010).
   PubMed Web of Science ®Google Scholar
• Imamura T, Doi Y, Arima H et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke40(2), 382–388 (2009).
   PubMed Web of Science ®Google Scholar
• Athyros VG, Tziomalos K, Karagiannis A, Wierzbicki AS, Mikhailidis DP. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? Curr. Opin. Cardiol.25(4), 406–410 (2010).
   PubMedGoogle Scholar
• Genser B, Marz W. Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis. Clin. Res. Cardiol.95(8), 393–404 (2006).
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Emberson J et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet376(9753), 1670–1681 (2010).
   PubMed Web of Science ®Google Scholar
• De Caterina R, Scarano M, Marfisi R et al. Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol.55(3), 198–211 (2010).
   PubMed Web of Science ®Google Scholar
• Fuentes B, Martinez-Sanchez P, Diez-Tejedor E. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovasc. Dis.27(Suppl. 1), 126–133 (2009).
   PubMedGoogle Scholar
• Abourbih S, Filion KB, Joseph L et al. Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am. J. Med.122(10), 962, e961–e968 (2009).
   Google Scholar
• Jun M, Foote C, Lv J et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet375(9729), 1875–1884 (2010).
   PubMed Web of Science ®Google Scholar
• Saha SA, Arora RR. Fibrates in the prevention of cardiovascular disease in patients with Type 2 diabetes mellitus – a pooled meta-analysis of randomized placebo-controlled clinical trials. Int. J. Cardiol.141(2), 157–166 (2009).
   PubMedGoogle Scholar
• Bruckert E, Labreuche J, Deplanque D, Touboul PJ, Amarenco P. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. J. Cardiovasc. Pharmacol.57(2), 267–272 (2011).
   PubMed Web of Science ®Google Scholar
• Chirovsky DR, Fedirko V, Cui Y, Sazonov V, Barter P. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Eur. J. Cardiovasc. Prev. Rehabil.16(4), 404–423 (2009).
   PubMedGoogle Scholar
• Sarwar N, Gao P, Seshasai SR et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet375(9733), 2215–2222 (2010).
   PubMed Web of Science ®Google Scholar
• Spellman CW. Achieving glycemic control: cornerstone in the treatment of patients with multiple metabolic risk factors. J. Am. Osteopath. Assoc.109(5 Suppl.), S8–S13 (2009).
   Google Scholar
• Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: an update. Nat. Rev. Cardiol.7(7), 369–375 (2010).
   PubMed Web of Science ®Google Scholar
• Reboldi G, Gentile G, Angeli F, Verdecchia P. Optimal therapy in hypertensive subjects with diabetes mellitus. Curr. Atheroscler. Rep.13(2), 176–185 (2011).
   PubMed Web of Science ®Google Scholar
• Lip GY, Boos CJ. Antithrombotic treatment in atrial fibrillation. Postgrad. Med. J.84(991), 252–258 (2008).
   PubMedGoogle Scholar
• Iwahana H, Ishikawa S, Ishikawa J et al. Atrial fibrillation is a major risk factor for stroke, especially in women: the Jichi Medical School Cohort Study. J. Epidemiol.21(2), 95–101 (2011).
   PubMedGoogle Scholar
• Lip GY, Rudolf M, Kakar P. Management of atrial fibrillation: the NICE guidelines. Int. J. Clin. Pract.61(1), 9–11 (2007).
   PubMedGoogle Scholar
• Perez A, Touchette DR, Didomenico RJ, Stamos TD, Walton SM. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost–effectiveness analysis. Pharmacotherapy31(6), 552–565 (2011).
   PubMed Web of Science ®Google Scholar
• Lip GY, Halperin JL, Tse HF. The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution? Chest139(4), 738–741 (2011).
   PubMedGoogle Scholar
• Moubarak G. Evolution of the strength of recommendations in guidelines for the management of atrial fibrillation. Int. J. Cardiol.149(3), 394–395 (2011).
   PubMedGoogle Scholar
• Stiell IG, Macle L. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can. J. Cardiol.27(1), 38–46 (2011).
   PubMedGoogle Scholar
• Fuster V, Ryden LE, Cannom DS et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation123(10), e269–e367 (2011).
   PubMedGoogle Scholar
• Tzeis S, Andrikopoulos G. Novel anticoagulants for atrial fibrillation: a critical appraisal. Angiology doi:10.1177/0003319711422808 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Jackson G. Tobacco: the most important preventable cause of cardiovascular disease. Int. J. Clin. Pract.64(3), 279–280 (2010).
   PubMedGoogle Scholar
• Girot M. [Smoking and stroke]. Presse Med.38(7–8), 1120–1125 (2009).
   PubMedGoogle Scholar
• O’Donnell M, Yusuf S. Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurol.8(4), 306–307 (2009).
   PubMedGoogle Scholar
• Bhat VM, Cole JW, Sorkin JD et al. Dose–response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke39(9), 2439–2443 (2008).
   PubMed Web of Science ®Google Scholar
• Truelsen T. Advances in population-based studies. Stroke41(2), e99–e101 (2010).
   Google Scholar
• Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ328(7455), 1519 (2004).
   PubMed Web of Science ®Google Scholar
• Lee PN, Forey BA. Environmental tobacco smoke exposure and risk of stroke in nonsmokers: a review with meta-analysis. J. Stroke Cerebrovasc. Dis.15(5), 190–201 (2006).
   PubMedGoogle Scholar
• Strazzullo P, D’Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke41(5), e418–e426 (2010).
   PubMed Web of Science ®Google Scholar
• Yatsuya H, Folsom AR, Yamagishi K, North KE, Brancati FL, Stevens J. Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study. Stroke41(3), 417–425 (2010).
   PubMed Web of Science ®Google Scholar
• Yatsuya H, Yamagishi K, North KE, Brancati FL, Stevens J, Folsom AR. Associations of obesity measures with subtypes of ischemic stroke in the ARIC Study. J. Epidemiol.20(5), 347–354 (2010).
   PubMedGoogle Scholar
• Vemmos K, Ntaios G, Spengos K et al. Association between obesity and mortality after acute first-ever stroke: the obesity–stroke paradox. Stroke42(1), 30–36 (2010).
   PubMedGoogle Scholar
• Sanchez-Moreno C, Jimenez-Escrig A, Martin A. Stroke: roles of B vitamins, homocysteine and antioxidants. Nutr. Res. Rev.22(1), 49–67 (2009).
   PubMed Web of Science ®Google Scholar
• Schurks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ341, c5702 (2010).
   PubMed Web of Science ®Google Scholar
• Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids45(10), 893–905 (2010).
   PubMed Web of Science ®Google Scholar
• Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr.91(3), 535–546 (2010).
   PubMed Web of Science ®Google Scholar
• Yamagishi K, Iso H, Yatsuya H et al. Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study. Am. J. Clin. Nutr.92(4), 759–765 (2010).
   PubMed Web of Science ®Google Scholar
• He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J. Hum. Hypertens.23(6), 363–384 (2009).
   PubMed Web of Science ®Google Scholar
• Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ339, b4567 (2009).
   PubMed Web of Science ®Google Scholar
• Agnoli C, Krogh V, Grioni S et al. A priori-defined dietary patterns are associated with reduced risk of stroke in a large italian cohort. J. Nutr. doi:10.3945/jn.111.140061 (2011) (Epub ahead of print).
   Google Scholar
• Liang W, Lee AH, Binns CW. Tea drinking, diet and ischemic stroke prevention in China: a future perspective. Expert Rev. Cardiovasc. Ther.7(11), 1447–1454 (2009).
   PubMedGoogle Scholar
• Buitrago-Lopez A, Sanderson J, Johnson L et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ343, d4488 (2011).
   PubMed Web of Science ®Google Scholar
• He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet367(9507), 320–326 (2006).
   PubMed Web of Science ®Google Scholar
• Scarborough P, Nnoaham KE, Clarke D, Capewell S, Rayner M. Modelling the impact of a healthy diet on cardiovascular disease and cancer mortality. J. Epidemiol. Community Health doi:10.1136/jech.2010.114520 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Stamler J. Diet–heart: a problematic revisit. Am. J. Clin. Nutr.91(3), 497–499 (2010).
   PubMedGoogle Scholar
• Klatsky AL. Alcohol and cardiovascular health. Physiol. Behav.100(1), 76–81 (2010).
   PubMed Web of Science ®Google Scholar
• Feigin VL, Rinkel GJ, Lawes CM et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke36(12), 2773–2780 (2005).
   PubMed Web of Science ®Google Scholar
• Sull JW, Yi SW, Nam CM, Choi K, Ohrr H. Binge drinking and hypertension on cardiovascular disease mortality in Korean men and women: a Kangwha cohort study. Stroke41(10), 2157–2162 (2010).
   PubMedGoogle Scholar
• Guiraud V, Amor MB, Mas JL, Touze E. Triggers of ischemic stroke: a systematic review. Stroke41(11), 2669–2677 (2010).
   PubMed Web of Science ®Google Scholar
• Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ342, d671 (2011).
   PubMed Web of Science ®Google Scholar
• Diep L, Kwagyan J, Kurantsin-Mills J, Weir R, Jayam-Trouth A. Association of physical activity level and stroke outcomes in men and women: a meta-analysis. J. Womens Health (Larchmt)19(10), 1815–1822 (2010).
   PubMed Web of Science ®Google Scholar
• Carnethon MR. Physical activity and cardiovascular disease: how much is enough? Am. J. Lifestyle Med.3(1 Suppl.), 44S–49S (2009).
   PubMedGoogle Scholar
• Boysen G, Krarup LH. Benefits of physical activity for stroke survivors. Expert Rev. Neurother.9(2), 147–149 (2009).
   PubMed Web of Science ®Google Scholar
• Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke36(6), 1330–1340 (2005).
   PubMed Web of Science ®Google Scholar
• Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int. J. Geriatr. Psychiatry22(7), 613–626 (2007).
   PubMed Web of Science ®Google Scholar
• Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA306(11), 1241–1249 (2011).
   PubMed Web of Science ®Google Scholar
• Salaycik KJ, Kelly-Hayes M, Beiser A et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke38(1), 16–21 (2007).
   PubMed Web of Science ®Google Scholar
• Liebetrau M, Steen B, Skoog I. Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds. Stroke39(7), 1960–1965 (2008).
   PubMedGoogle Scholar
• Arbelaez JJ, Ariyo AA, Crum RM, Fried LP, Ford DE. Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study. J. Am. Geriatr. Soc.55(11), 1825–1830 (2007).
   PubMed Web of Science ®Google Scholar
• Peters R, Pinto E, Beckett N et al. Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET). Age Ageing39(4), 439–445 (2010).
   PubMed Web of Science ®Google Scholar
• Kamphuis MH, Geerlings MI, Giampaoli S, Nissinen A, Grobbee DE, Kromhout D. The association of depression with cardiovascular mortality is partly explained by health status. The FINE Study. J. Affect. Disord.114(1–3), 184–192 (2009).
   PubMedGoogle Scholar
• Smoller JW, Allison M, Cochrane BB et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch. Intern. Med.169(22), 2128–2139 (2009).
   PubMed Web of Science ®Google Scholar
• Hamer M, Molloy GJ, Stamatakis E. Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J. Am. Coll. Cardiol.52(25), 2156–2162 (2008).
   PubMed Web of Science ®Google Scholar
• Tsutsumi A, Kayaba K, Kario K, Ishikawa S. Prospective study on occupational stress and risk of stroke. Arch. Intern. Med.169(1), 56–61 (2009).
   PubMedGoogle Scholar
• Surtees PG, Wainwright NW, Luben RN, Wareham NJ, Bingham SA, Khaw KT. Psychological distress, major depressive disorder, and risk of stroke. Neurology70(10), 788–794 (2008).
   PubMed Web of Science ®Google Scholar
• Ohira T. Psychological distress and cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS). J. Epidemiol.20(3), 185–191 (2010).
   PubMedGoogle Scholar
• Jood K, Redfors P, Rosengren A, Blomstrand C, Jern C. Self-perceived psychological stress and ischemic stroke: a case–control study. BMC Med.7, 53 (2009).
   PubMedGoogle Scholar
• May M, McCarron P, Stansfeld S et al. Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study. Stroke33(1), 7–12 (2002).
   PubMed Web of Science ®Google Scholar
• Smith SCJ, Zheng ZJ. The impending cardiovascular pandemic in China. Circ. Cardiovasc. Qual. Outcomes3(3), 226–227 (2010).
   PubMedGoogle Scholar
• Moran A, Gu D, Zhao D et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model – China. Circ. Cardiovasc. Qual. Outcomes3(3), 243–252 (2010).
   PubMed Web of Science ®Google Scholar
• He J, Gu D, Wu X et al. Major causes of death among men and women in China. N. Engl. J. Med.353(11), 1124–1134 (2005).
   PubMed Web of Science ®Google Scholar
• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet367(9524), 1747–1757 (2006).
   PubMed Web of Science ®Google Scholar
• Li H, Meng Q, Sun X, Salter A, Briggs NE, Hiller JE. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J. Hypertens.28(3), 432–438 (2010).
   PubMed Web of Science ®Google Scholar
• Pang W, Li Z, Sun Z et al. Prevalence of hypertension and associated factors among older rural adults: results from Liaoning Province, China. Med. Princ. Pract.19(1), 22–27 (2010).
   PubMedGoogle Scholar
• Joshi R, Jan S, Wu Y, MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J. Am. Coll. Cardiol.52(23), 1817–1825 (2008).
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang G, Choi BC et al. Surveillance of trend and distribution of stroke mortality by subtype, age, gender, and geographic areas in Tianjin, China, 1999–2006. Int. J. Stroke4(3), 169–174 (2009).
   PubMedGoogle Scholar
• Jekal Y, Yun JE, Park SW, Jee SH, Jeon JY. The relationship between the level of fatness and fitness during adolescence and the risk factors of metabolic disorders in adulthood. Korean Diabetes J.34(2), 126–134 (2010).
   PubMedGoogle Scholar
• Juonala M, Viikari JS, Kahonen M et al. Life-time risk factors and progression of carotid atherosclerosis in young adults: the Cardiovascular Risk in Young Finns study. Eur. Heart J.31(14), 1745–1751 (2010).
   PubMed Web of Science ®Google Scholar
• Howard VJ, Woolson RF, Egan BM et al. Prevalence of hypertension by duration and age at exposure to the stroke belt. J. Am. Soc. Hypertens.4(1), 32–41 (2010).
   PubMedGoogle Scholar
• Sacco R, Smith S, Holmes D et al. Accelerating progress on non-communicable diseases. Lancet doi:10.1016/S0140-6736(11)61477-3 (2011) (Epub ahead of print).
   PubMedGoogle Scholar